Erweiterte Suche
Nachrichten (7)
Unternehmen (7)
Ubiquoss Inc. ist ein in Korea ansässiges Unternehmen, das sich hauptsächlich mit der Herstellung und dem Vertrieb von Netzwerkausrüstung beschäftigt. Das Produktportfolio des Unternehmens umfasst Ethernet-Switches, FTTH-Ausrüstung (Fiber-to-the-Home) ein ...
Helius Medical Technologies, Inc. ist ein Neurotech-Unternehmen im Bereich der Medizintechnik. Es konzentriert sich auf neurologische Defizite mit Hilfe einer oral anwendbaren Technologieplattform, die die Fähigkeit des Gehirns, physiologische Kompensatio ...
Eoptolink Technology Inc. ist ein in China ansässiges Unternehmen, das sich hauptsächlich mit der Forschung und Entwicklung, der Herstellung und dem Verkauf von optischen Modulen beschäftigt. Zu den Hauptprodukten des Unternehmens gehören optische Punkt-z ...
Lightron Fiber-Optic Devices Inc, ehemals LIGHTRON INC, ist ein in Korea ansässiges Unternehmen, das sich mit der Bereitstellung von optischen Modullösungen für die Kommunikation beschäftigt. Das Unternehmen bietet passive optische Netzwerkeinheiten (PON) ...
PC3 - Investment Joint Stock Company (PC3-INVEST) ist ein in Vietnam ansässiges Unternehmen, das in der Energiebranche tätig ist. Das Unternehmen ist mit dem Management des 14-Megawatt-(MW)-Wasserkraftwerks Dak Pone im Bezirk Kon Plong in der Provinz Kon ...
SOLiD, Inc. ist ein in Korea ansässiges Unternehmen, das sich mit der Herstellung von Kommunikationsgeräten wie Breitband-Codemultiplex-Vielfachzugriff (WCDMA) Repeatern und LTE-Geräten (Long Term Evolution) beschäftigt. Das Unternehmen produziert hauptsä ...
OE Solutions Co., Ltd. ist ein in Korea ansässiges Unternehmen, das sich hauptsächlich mit der Herstellung und dem Vertrieb von optischen Transceivern beschäftigt. Das Unternehmen bietet hauptsächlich optische Transceiver-Lösungen für drahtlose und drahtg ...
Insiders
Jaume Pons is the founder of ALX Oncology Ltd.
(founded in 2015) where he holds the title of President, Chief Executive Officer & Director.
He is also the founder of ALX Oncology Holdings, Inc. (founded in 2015) where he holds the title of President, Director & Chief Scientific Officer.
Currently, Dr. Pons is the President & Chief Executive Officer of ALX Oncology, Inc. He is also a Director at Tallac Therapeutics, Inc., Alexo Therapeutics International, Sirpant Therapeutics, and LSV Capital Management LLC, where he serves as a Scientific Advisor.
Additionally, he is a Venture Partner at venBio Partners LLC since 2015.
In the past, Dr. Pons worked as the Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
He also held the position of Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Dr. Pons completed his graduate studies at the University of California, Berkeley.
He also holds undergraduate, graduate, and doctorate degrees from Universitat Autònoma de Barcelona.
Jaume Carol Paach hat die Position des Global Manufacturing Director bei Fluidra SA inne.
Jaume Perdigó Pons is currently an Investment Director at Miura Partners SGEIC SA since 2022.
He is also a Board Member at Citrico Global SL and TIERRA - Ingeniería y Paisajismo SL.
In the past, he worked as an Investment Analyst at Suma Capital SGEIC SA from 2016 to 2017 and as an Investment Banking Analyst at Greenhill & Co. Spain Ltd.
from 2017 to 2019.
Mr. Perdigó Pons completed his undergraduate degree at ESADE Business School in 2016.
John M.
Pons is currently a Director at Rincon 222 LLC, RP Investments I LLC, Rincon 115 LLC, RP Investments II LLC, and Rincon SH2825 LLC.
He is also the Secretary, EVP & General Counsel at Cole Capital Partners LLC, Cole Realty Advisors LLC, Cole REIT Advisors LLC, Cole REIT Advisors II LLC, and Cole REIT Advisors III LLC.
In the past, Mr. Pons served as an Independent Director at Nexpoint Multifamily Capital Trust, Inc. He was also the Secretary at Cole Credit Property Trust, Inc. and Cole Credit Property Trust II, Inc. Additionally, he held the position of Secretary, Executive VP & General Counsel at Cole Real Estate Investments, Inc. and was an Associate General Counsel & Assistant Secretary at GE Capital Franchise Finance Corp.
He also served in the US Air Force as a Principal.
Mr. Pons completed his graduate degree at Central Michigan University and his undergraduate degree at Colorado State University.
He also obtained a graduate degree from the University of Denver in 1995.
Jean-Luc Pons is currently a Director at APF France handicap since 2017.
Joanne Pons has worked as a Vice President-Engineering at MyVest Corp.
since 2002.
Jean-Michel Pons is currently the Managing Director at Hima Cement Ltd.
and also holds the position of Executive Director at Bamburi Cement Co. Ltd.
since 2019.
Previously, he worked as the Director of Algeria & Serbia Business Development at Holcim Ltd.
Jaume Ferre is currently the Chief Technology Officer at Wallbox NV since 2021.
He completed his undergraduate degree at the Polytechnic University of Catalonia.
Jaume Amat currently works as a Director at VCN Biosciences SL.
Jaume Claramunt currently works as a Director at Fundació CTM Centre Tecnològic.
Jaume Llobet is currently the Director of Finance & Administration at Parlem Telecom Companyia de Telecomunicacions SA. Previously, he worked as the Chief Financial Officer at Hanesbrands Spain SA.
Jaume Sallares worked as the Chief Marketing Officer at Formula E Holdings Ltd.
Jaume Solá is currently the Chief Financial Officer at Enerside Energy SA. Prior to his current position, he worked as an Investment Analyst at Highgrowth Partners SGECR SA from 2007 to 2011.
Mr. Solá holds a graduate degree from the University of Barcelona, which was conferred in 2006.
He also obtained an MBA from the University of Navarra in 2012.
Jaume Llansana is the founder of Ultramagic SA, which was founded in 1978.
Jaume Salles has worked as an Operations Director & Partner at Steros GPA Innovative SL since 2017.
François Pons currently works as a Director of Business Development at GENOME express SA.
Mr. Demian Pons is Long & Short Portfolio Manager at Verde Asset Management SA.
He began his career at Credit Suisse First Boston in Investment Banking in 2002.
I2010 he joined Credit Suisse Hedging-Griffo Wealth Management SA as Porfolio Manager.
Prior to CSHG, he worked as Analyst & Equities Manager by Citadel Investment Group in Chicago and Brioghtpint Capital in London.
Mr. Demian holds a degree in Business Adminstration from University of Michigan.
Keine Ergebnisse zu dieser Suche
- Börse
- Erweiterte Suche
- Jaume Pons